Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001326110-25-000114
Filing Date
2025-08-05
Accepted
2025-08-05 07:36:29
Documents
122
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ibrx-20250630.htm   iXBRL 10-Q 3099481
2 EX-31.1 ibrx-2025630x10qexhibit311.htm EX-31.1 11145
3 EX-31.2 ibrx-2025630x10qexhibit312.htm EX-31.2 10913
4 EX-32.1 ibrx-2025630x10qexhibit321.htm EX-32.1 5199
5 EX-32.2 ibrx-2025630x10qexhibit322.htm EX-32.2 4944
11 2025 PIPELINE ibrx-20250630_g1.jpg GRAPHIC 174354
  Complete submission text file 0001326110-25-000114.txt   15882650

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ibrx-20250630.xsd EX-101.SCH 102466
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ibrx-20250630_cal.xml EX-101.CAL 145643
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ibrx-20250630_def.xml EX-101.DEF 671662
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ibrx-20250630_lab.xml EX-101.LAB 1122655
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ibrx-20250630_pre.xml EX-101.PRE 922766
125 EXTRACTED XBRL INSTANCE DOCUMENT ibrx-20250630_htm.xml XML 2404124
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (844) 696-5235
ImmunityBio, Inc. (Filer) CIK: 0001326110 (see all company filings)

EIN.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37507 | Film No.: 251182826
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)